BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18555525)

  • 1. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
    Fend F; Horn T; Koch I; Vela T; Orazi A
    Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
    Kvasnicka HM
    Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
    Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
    Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
    Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
    Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
    Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
    Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
    Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A; Outeriño J; Martín Calderín F; Benítez J
    Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases].
    Tassies D; Feliu E; Villamor N; Urbano-Ispizua A; Cervantes F; Campo E; Ordi J; Vernet M; Pujol R; López R
    Med Clin (Barc); 1990 Nov; 95(16):618-20. PubMed ID: 2097454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy].
    Itoh K; Kashimura T; Kobayashi Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Kusumoto S; Fukuda M; Ino H; Murohashi I; Jinnai I; Yoshida S; Bessho M; Saitoh M; Hirashima K
    Rinsho Ketsueki; 1999 Feb; 40(2):129-34. PubMed ID: 10199207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous features of Ph-negative CML--possible existence of Ph-negative, bcr-rearrangement-negative CML.
    Kato Y; Sawada H; Tashima M; Yumoto Y; Okuda T; Ueda T; Yamagishi M; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1004-12. PubMed ID: 2588950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
    van der Plas DC; Grosveld G; Hagemeijer A
    Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.